Esra Seyran | Medical Hypotheses | Best Researcher Award

Assist. Prof. Dr. Esra Seyran | Medical Hypotheses | Best Researcher Award

Assistant Professor at Cumhuriyet University, Turkey

Dr. Esra Seyran is a distinguished molecular biologist and biochemist currently serving as an Assistant Professor at Cumhuriyet University, Turkey. With a Ph.D. in Biochemistry and Molecular Biology from the University of Arkansas, USA, her academic journey spans diverse fields including plant science, protein chemistry, and nanotechnology. She brings extensive international experience, notably as a Scientific Project Officer at the European Commission’s Joint Research Center in Belgium, where she contributed to biosafety and GMO policy development. Dr. Seyran has a strong research portfolio with over 15 publications in high-impact journals, focusing on recombinant protein expression, disease biomarkers, antifungal targets, and nanoparticle-based therapeutic and industrial applications. Her work has earned her prestigious fellowships from institutions such as the United Nations, FAO, and NSF. Notably, she holds a 2023 Turkish patent for a nanomaterial-based COVID-19 treatment formulation. A dedicated educator with two decades of teaching experience in the U.S. and Turkey, Dr. Seyran exemplifies academic excellence, innovation, and interdisciplinary research leadership.

Professional Profile 

🎓 Education of Dr. Esra Seyran

Dr. Esra Seyran has pursued a rich and multidisciplinary academic path across prestigious institutions in the USA, Italy, and Turkey. She earned her Ph.D. in Biochemistry and Molecular Biology (2006–2011) from the University of Arkansas, where her dissertation focused on the expression, purification, and redox-dependent disulfide bonding in human Von Willebrand Factor A domains. Prior to that, she completed her M.Sc. in Plant Science (2002–2005) at the same university, with research on temperature interactions in Puccinia striiformis isolates. In 2000–2001, she undertook a post-bachelor’s specialization in Plant-Microbe Interactions at the Instituto Agronomico Mediterraneo di Bari in Italy, supported by an Italian Foreign Ministry Fellowship. Her academic foundation was laid with a B.Sc. in Biochemistry from Ege University, Izmir, Turkey (1993–1999). This diverse and international educational background has empowered her to work at the intersection of molecular biology, plant pathology, and biochemical research.

💼 Professional Experience of Dr. Esra Seyran

Dr. Esra Seyran has amassed a diverse and impactful professional career spanning academia, international research institutions, and policy advisory roles. She currently serves as an Assistant Professor at Cumhuriyet University’s Department of Molecular Biology and Genetics in Turkey, where she has been a faculty member since 2014. Prior to her current role, she worked as an Instructor at the same university from 2014 to 2021, teaching advanced courses in biochemistry, toxicology, and genetics. Between 2011 and 2013, Dr. Seyran held the position of Scientific Project Officer at the European Commission’s Joint Research Center (DG-JRC) in Geel, Belgium, where she provided policy advice on biosafety, GMOs, and pesticide regulation, while contributing to capacity-building efforts in alignment with EU standards. Her early career includes roles as a Teaching Assistant in the Department of Chemistry and Biochemistry (2006–2011) and a Research Assistant in Plant Pathology (2002–2005) at the University of Arkansas, where she also engaged in undergraduate instruction across a range of chemistry and biochemistry subjects. This blend of research, teaching, and international policy work reflects Dr. Seyran’s multifaceted expertise and professional versatility.

🔬 Research Interests of Dr. Esra Seyran

Dr. Esra Seyran’s research interests lie at the intersection of biochemistry, molecular biology, plant pathology, and nanotechnology, with a strong emphasis on translational and interdisciplinary science. Her work focuses on recombinant protein expression and purification, particularly the structural and functional analysis of Von Willebrand Factor domains, which has implications in cardiovascular and hematological disorders. She is also deeply involved in studying biochemical markers for metabolic and macrovascular diseases, such as diabetes. Dr. Seyran explores site-specific protein modifications, such as glycation and acetylation, and their impact on drug-protein interactions. Additionally, she has contributed to the development of nanoparticle-based materials for both therapeutic applications (e.g., COVID-19 treatment formulations) and industrial innovations, including corrosion inhibitors. Her early research in plant-microbe interactions and fungal pathogens also reflects a continued interest in agricultural biotechnology and host-pathogen dynamics. With this broad yet integrated focus, Dr. Seyran aims to bridge fundamental biochemical research with real-world applications in medicine, agriculture, and material science.

🏅 Awards and Honors of Dr. Esra Seyran

Dr. Esra Seyran has been recognized with numerous prestigious awards and fellowships throughout her academic and professional journey, reflecting her excellence in research, innovation, and international collaboration. In 2016, she was honored with the United Nations Arturo Falaschi Research Fellowship, acknowledging her contributions to molecular biology. She also received the FAO Training Fellowship in 2012 for her work on obsolete pesticide management. During her doctoral studies, she was awarded the Distinguished Doctoral Fellowship by the University of Arkansas Department of Chemistry in 2007, and the same year secured a National Science Foundation Scholarship for advanced training in microbial genetics at the Craig Venter Institute. Earlier accolades include the Asia Rice Foundation Research Award in 2006, and the Graduate School Travel Award from the University of Arkansas in 2004. Dr. Seyran also benefited from the Italian Foreign Ministry Cultural Exchange Scholarship (2000–2001), which supported her studies in plant-microbe interactions in Italy. These honors highlight her outstanding academic potential, international impact, and dedication to scientific advancement.

🏁 Conclusion

Dr. Esra Seyran presents a highly competitive and well-rounded profile suitable for the Best Researcher Award. Her work bridges cutting-edge biochemistry, biomedical innovation, agricultural science, and public policy, making her a rare multidisciplinary contributor. Her global research footprint, commitment to teaching, technical competencies, and novel contributions (e.g., patent) strongly support her eligibility and worthiness for recognition.

📚 Publications Top Noted

  1. Title: Aggressiveness of Puccinia striiformis f. sp. tritici isolates in the south-central United States
    Authors: EA Milus, E Seyran, R McNew
    Year: 2006
    Cited by: 190
  2. Title: New breeding techniques and their possible regulation
    Authors: E Seyran, W Craig
    Year: 2018
    Cited by: 23
  3. Title: Examination of the rice blast pathogen population diversity in Arkansas, USA – Stable or unstable?
    Authors: JC Correll, EJ Boza, E Seyran, RD Cartwright, Y Jia, FN Lee
    Year: 2009
    Cited by: 20
  4. Title: A preliminary characterization of the rice blast fungus on ‘Banks’ rice
    Authors: FN Lee, RD Cartwright, Y Jia, JC Correll, KAK Moldenhauer, JW Gibbons, V Boyett, E Zhou, E Boza, E Seyran
    Year: 2004
    Cited by: 20
  5. Title: New Races of Puccinia striiformis f. sp. tritici More Aggressive Than Older Races
    Authors: ESE Milus
    Year: 2005
    Cited by: 9
  6. Title: Aggressiveness of Puccinia striiformis f. sp. tritici
    Authors: EA Milus, E Seyran, R McNew
    Year: 2006
    Cited by: 3
  7. Title: Fungal homoserine transacetylase: a potential antifungal target
    Authors: E Seyran
    Year: 2021
    Cited by: 2
  8. Title: Isolate by temperature interaction for aggressiveness among isolates of Puccinia striiformis f. sp. tritici
    Authors: E Seyran, EA Milus
    Year: 2004
    Cited by: 2
  9. Title: The effects of aspirin acetylation of human serum albumin on its interactions with methotrexate
    Authors: Esra Seyran, Serap Cetinkaya
    Year: 2025
    Cited by: 1
  10. Title: Nanoparticle-Based Corrosion Inhibitors
    Authors: E Seyran, G Tüzün, S Çetinkaya, B Tüzün
    Year: 2024
    Cited by: 1

Shahbaz Ul Haq | Medical Hypotheses | Best Researcher Award

Shahbaz Ul Haq | Medical Hypotheses | Best Researcher Award

Postdoctoral at Shantou university medical college, China

Dr. Shahbaz Ul Haq is an accomplished veterinary scientist and postdoctoral researcher at Shantou University Medical College, China. With a Ph.D. in Basic Veterinary Medicine from the Chinese Academy of Agricultural Sciences, his work focuses on antimicrobial resistance (AMR) and zoonotic infections. His groundbreaking research investigates the synergistic potential of artemisinin derivatives to boost antibiotic efficacy against multidrug-resistant E. coli. Dr. Haq has held technical leadership roles in Pakistan’s veterinary industry, implementing evidence-based treatment protocols and exploring alternatives to antibiotics in livestock. He has authored impactful publications in top-tier journals like Frontiers in Veterinary Science and European Journal of Pharmacology. Dr. Haq has also been honored as a “Shantou High-Level Talent” and received the “Best Researcher Award” by ScienceFather. With international training, collaborative projects, and a strong publication record, he is a recognized authority in veterinary microbiology and One Health.

Publication Profile

Google Scholar

Education

Dr. Shahbaz Ul Haq holds a Ph.D. in Basic Veterinary Medicine from the Chinese Academy of Agricultural Sciences (2018–2022), where he focused on enhancing antibiotic activity through artemisinin derivatives. His coursework included advanced studies in immunology, microbiology, veterinary epidemiology, and Chinese culture. He earned his M.Phil. in Clinical Medicine and Surgery from the University of Agriculture, Faisalabad (2016–2018), conducting a comparative study on udder edema in dairy goats. Earlier, he completed a Doctor of Veterinary Medicine (DVM) degree from the same university (2010–2015), with a strong foundation in parasitology, virology, public health, and pathology. His academic path reflects a consistent emphasis on veterinary health, disease management, and clinical research. He also undertook several international workshops and advanced trainings in veterinary diagnostics, AMR surveillance, and zoonotic disease control across China, Morocco, Italy, and Pakistan.

Experience

Dr. Haq currently serves as a Postdoctoral Researcher at Shantou University Medical College, China, where his research addresses multidrug-resistant bacteria and antibiotic resistance. Previously, he worked as a Technical Manager at Polaris Life Sciences in Pakistan (2022–2023), focusing on reducing antibiotic residues in food through alternatives like probiotics. As Technical Executive at Forward Solutions (2015–2016), he explored mineral supplementation and metabolic disorders in livestock. He also interned at Sarbuland Dairy Farm, learning dairy management protocols. Dr. Haq has actively contributed to project proposals under the China Postdoctoral Science Foundation and National Natural Science Fund of China. He has participated as a speaker in numerous international conferences and workshops on animal health, veterinary biotechnology, and traditional medicine. With strong field and laboratory experience, he bridges academic research and real-world veterinary challenges.

Awards and Honors

Dr. Shahbaz Ul Haq has received notable national and international recognition for his research contributions. He was honored as a “Shantou High-Level Talent” in China, a prestigious recognition of exceptional scientific contributions. In 2025, he received the “Best Researcher Award” in Traditional Medicine from ScienceFather. He also serves as an Editorial Board Member for the New Scientists Awards, under Scifax Company Group. His academic journey was supported by competitive scholarships, including the Chinese Government Scholarship (CGS) for his Ph.D., and the Punjab Educational Endowment Fund (PEEF) for his M.Phil. Dr. Haq has presented at numerous international forums, including conferences in Italy, Morocco, China, and Pakistan. His participation in postdoctoral research forums and his leadership in AMR-focused projects further solidify his standing as a rising global voice in veterinary science and One Health research.

Research Focus

Dr. Haq’s research is centered on antimicrobial resistance (AMR), zoonotic pathogens, and veterinary pharmacology. His Ph.D. research demonstrated the synergistic effect of artemisinin derivatives in enhancing β-lactam and fluoroquinolone efficacy against multidrug-resistant E. coli, offering new hope in the fight against AMR. At Shantou University, his postdoctoral work continues to explore novel combinations of natural compounds and conventional antibiotics. Dr. Haq is also active in genetic epidemiology, studying mitochondrial gene variation in zoonotic parasites like Taenia multiceps, Clonorchis sinensis, and Echinococcus granulosus. His work integrates bioinformatics, microbial genomics, drug resistance profiling, and public health risk assessment. In applied veterinary settings, he has led research into probiotic alternatives, parasite control, and clinical treatment protocols to reduce antibiotic residues in livestock products. His interdisciplinary approach spans One Health, molecular microbiology, and pharmacogenomics.

Publication Top Notes

Revealing novel cytb and nad5 genes-based population diversity and benzimidazole resistance in Echinococcus granulosus of bovine origin

Anticoccidial Activity of Qinghao Powder Against Eimeria tenella in Broiler Chickens

Toxicological evaluation of the ultrasonic extract from Dichroae radix in mice and wistar rats

Regulation and analysis of the diversity of intestinal microbiota in SD rats by Danggui Buxue Tang (DBT) fermented with Bacillus subtilis

Drug resistance modulation of dairy MRSA through Berberine. Artesunate and Quercetin in Combination with β-Lactams

Subclinical Mastitis in Small-Holder Dairy Herds of Gansu Province, Northwest China: Prevalence, Bacterial Pathogens, Antimicrobial Susceptibility, and Risk Factor Analysis

Comparison of photosensitized tissue bonding and vet glue in closure of incisional wounds.

 

Angela Caiado | Medical Hypotheses | Best Researcher Award

Angela Caiado | Medical Hypotheses | Best Researcher Award

Dr Angela Caiado, Universidade de Sao Paulo, Brazil

Dr. Angela Caiado is a distinguished medical professional and academic, currently pursuing her PhD in Radiology at the University of São Paulo (USP), Brazil. With over two decades of expertise, she specializes in abdominal and pelvic imaging with significant contributions to colorectal cancer diagnosis, inflammatory bowel disease, and liver transplantation imaging. She holds an MD from USP and is also completing an MBA in Business Management from FGV, reflecting her commitment to both clinical excellence and leadership. As Head of Radiology at Grupo Fleury and a former instructor at Hospital das Clínicas – USP, Dr. Caiado has mentored many budding radiologists. Her research is internationally recognized, with presentations at RSNA, ESGAR, and PANCCO. She has also collaborated globally, including with Harvard T.H. Chan School of Public Health. Her deep dedication to translational imaging science and patient care integration makes her a highly deserving candidate for the Best Researcher Award.

Publication Profile

Scopus

Education

Dr. Caiado earned her Doctor of Medicine (MD) degree from the University of São Paulo (USP), Brazil, where she also completed her residency in Radiology and Diagnostic Imaging (2001–2004) and specialized training in Abdominal Imaging (2004–2005). Currently, she is pursuing a PhD in Radiology at USP, with her thesis focusing on CT colonography with mannitol preparation for detecting synchronous tumors in colorectal cancer, under the guidance of Prof. Carlos Buchpiguel. Complementing her medical background, she is undertaking an MBA in Business Management at Fundação Getúlio Vargas (FGV), Brazil, to enhance her healthcare leadership skills. Her strong academic trajectory showcases a rare blend of clinical depth and managerial vision, enabling her to bridge radiology science and healthcare operations effectively. This comprehensive education foundation has empowered her to drive impactful research and assume senior clinical leadership roles while actively contributing to academic advancement in radiology.

Experience

Dr. Angela Caiado has held pivotal roles in clinical radiology for over 20 years. Since 2004, she has been the Head of Radiology and Diagnostic Imaging at Grupo Fleury, one of Brazil’s most prestigious medical institutions, where she also serves as a Senior Radiologist specializing in abdominal and pelvic imaging. From 2004 to 2017, she served as an Assistant Radiologist and residency instructor at Hospital das Clínicas – USP. Her academic engagements include an international teaching role at Harvard T.H. Chan School of Public Health as an Assistant Professor in the PPCR Program. Dr. Caiado also broadened her expertise through an observer fellowship at The Royal Marsden Hospital in London in 2017. Her career exemplifies a seamless integration of leadership, education, and clinical service, underscoring her versatility and dedication to advancing medical imaging, patient care, and interdisciplinary training.

Awards and Honors

Dr. Angela Caiado has earned multiple awards and accolades for her contributions to radiology and clinical research. Her presentations have been consistently recognized at the Jornada Paulista de Radiologia, where she received several awards for her excellence in abdominal and pelvic imaging studies. She has been a regular invited speaker at major radiological and gastrointestinal conferences such as RSNA, ESGAR, FICARE, and PANCCO, reflecting peer recognition of her work’s quality and clinical impact. As a global contributor, her teaching role in the Harvard PPCR program further highlights her reputation in academic circles. She has also contributed chapters to landmark radiology and gastrointestinal textbooks published by Elsevier, Manole, Atheneu, and Springer. These accolades demonstrate her thought leadership and dedication to enhancing medical knowledge across radiology disciplines.

Research Focus

Dr. Angela Caiado’s research is centered on advanced imaging in gastrointestinal and hepatobiliary diseases, particularly colorectal cancer, inflammatory bowel disease (IBD), and liver transplantation. Her PhD research focuses on using CT colonography with mannitol preparation to improve the detection of synchronous tumors in obstructive colorectal cancer. She is also engaged in multiparametric MRI studies and elastography for liver and spleen evaluations, with promising applications in myelofibrosis and chronic liver conditions. Dr. Caiado’s work aims to refine diagnostic accuracy, improve pre-surgical assessments, and contribute to non-invasive disease monitoring. Her approach often emphasizes radiological-surgical integration, fostering improved multidisciplinary collaboration. Her translational research consistently bridges clinical radiology and patient-centered outcomes, reinforcing her standing as a trailblazer in abdominal imaging and radiological innovation.

Publication Top Notes